# A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.

> **NCT06493578** · PHASE2 · TERMINATED · sponsor: **Vyne Therapeutics Inc.** · enrollment: 205 (actual)

## Conditions studied

- Non-segmental Vitiligo

## Interventions

- **DRUG:** VYN201 Gel
- **DRUG:** Vehicle Gel

## Key facts

- **NCT ID:** NCT06493578
- **Lead sponsor:** Vyne Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-06-04
- **Primary completion:** 2025-07-10
- **Final completion:** 2025-09-30
- **Target enrollment:** 205 (ACTUAL)
- **Why stopped:** Business Decision
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06493578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06493578, "A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06493578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*